about
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...
Read More
32.59
-0.09
(-0.28%)
930.2K
XNAS Volume
XNAS 11 Dec, 2025 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Liquidia Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..